Aspire Indiana Health Elwood Outpatient Offices
-
Services:
- Substance use disorder education
- Hepatitis education, counseling, or support
- HIV or AIDS education, counseling, or support
- Smoking/vaping/tobacco cessation counseling
- Group counseling
- Health education services other than HIV/AIDS or hepatitis
- Family counseling
- Individual counseling
- Sliding fee scale (fee is based on income and other factors)
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Other contracted prescribing entity
- Discharge Planning
- This facility administers/prescribes medication for alcohol use disorder
- Relapse prevention
- Substance use disorder counseling
- Anger management
- Telemedicine/telehealth therapy
- Matrix Model
- Trauma-related counseling
- Motivational interviewing
- Community reinforcement plus vouchers
- Cognitive behavioral therapy
- Specially designed program for DUI/DWI clients
- Federal, or any government funding for substance use treatment programs
- Cash or self-payment
- Medicare
- State-financed health insurance plan other than Medicaid
- Medicaid
- SAMHSA funding/block grants
- Private health insurance
- Federal military insurance (e.g., TRICARE)
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient
- Regular outpatient treatment
- Adult women
- Clients who have experienced trauma
- Adult men
- Complete medical history/physical exam
- Screening for substance use
- Comprehensive mental health assessment
- Screening for tobacco use
- Comprehensive substance use assessment
- Screening for mental disorders
- Vaping not permitted
- Transportation assistance
- Mental health services
- Case management service
- Integrated primary care services
- Social skills development
- Early intervention for HIV
- Domestic violence services, including family or partner
- Suicide prevention services
- State mental health department
- State Substance use treatment agency
- The Joint Commission
- Federally Qualified Health Center
- Employment counseling or training
- Housing services
- Assistance with obtaining social services
- Recovery coach
- Mentoring/peer support
- Buprenorphine with naloxone
- Medication for mental disorders
- Medications for Hepatitis C treatment
- Naltrexone (extended-release, injectable)
- Disulfiram
- Nicotine replacement
- Clonidine
- Acamprosate (CampralĀ®)
- Naltrexone (oral)
- Medications for pre-exposure to prophylaxis
- Non-nicotine smoking/tobacco cessation
- Treatment for gambling disorder
- Sign language services for the deaf and hard of hearing
- Female
- Male
- Smoking not permitted
- Private non-profit organization
- Other contracted prescribing entity
- Prescribes naltrexone
- Maintenance service with medically supervised withdrawal after stabilization
- Relapse prevention with naltrexone
- Accepts clients using MAT but prescribed elsewhere
- Buprenorphine maintenance
- Prescribes buprenorphine
- TB screening
- STD testing
- Testing for Hepatitis C (HCV)
- Drug or alcohol urine screening
- HIV testing
Education and Counseling Services
Payment Assistance Available
Opioid Medications used in Treatment
External Source of Medications Used for Alcohol Use Disorder Treatment
Transitional Services
Type of Alcohol Use Disorder Treatment
Treatment Approaches
Exclusive Services
Payment/Insurance/Funding Accepted
Type of Care
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Special Programs/Groups Offered
Assessment/Pre-treatment
Facility Vaping Policy
Ancillary Services
License/Certification/Accreditation
Recovery Support Services
Pharmacotherapies
Other Services
Language Services
Gender Accepted
Facility Smoking Policy
Facility Operation (e.g., Private, Public)
External Opioid Medications Source
Type of Opioid Treatment
Testing
